Director, Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology
Human and Translational Immunology Program
The mission of the Human and Translational Immunology (HTI) Program at the Yale School of Medicine is to accelerate the application of new developments in the field of immunology to the treatment of human diseases. With its administrative base within the Department of Immunobiology and its core laboratories housed in the Amistad building and the George Street Facility, the HTI program is open to all members of the Yale School of Medicine faculty with an interest in human immunology and the contributions of immunology to disease. The HTI faculty study the immunologic aspects of a very broad range of human diseases, encompassing investigations in the fields of cancer and cancer therapeutics, transplantation of solid organs and stem cells; autoimmune diseases including endocrine diseases such as Type 1 diabetes, rheumatologic diseases including rheumatoid arthritis and systemic lupus erythematosis; pulmonary diseases including asthma and chronic obstructive pulmonary disease; neurologic diseases such as multiple sclerosis; gastrointestinal diseases such as Crohn's disease, celiac sprue, and ulcerative colitis; and many others. HTI programs offer investigators the opportunity to interact with other clinical and basic scientists to develop investigations in the treatment of human disease, and access to resources to support this work. Providing resources to develop novel therapies that are in the early stages (Phase I/II) of development are a top priority of HTI, which will assist in preparing applications to the Immune Tolerance Network, the FOCIS Centers of Excellence, Trialnet and other multi-institutional organizations.
The HTI seminar series highlights studies of human disease and features nationally recognized internal and outside speakers. A training grant to develop the careers of new investigators with expertise in human translational immunology and support the work of these individuals in the laboratories of the HTI faculty is planned.
HTI membership is open to Yale faculty interested in translational immunology. Approval for membership is given by the HTI steering committee.
Professor, Obstetrics, Gynecology & Reproductive Sciences; Director, Division of Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences
Professor of Medicine (Immunology)
Associate Professor of Medicine; Director, Fellowship Program, Digestive Diseases
Professor Emeritus of Immunobiology; Member of HTI and VBT
Waldemar Von Zedtwitz Professor of Medicine (Rheumatology) and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy, & Immunology; Rheumatologist in Chief, Rheumatology; Affiliated Faculty, Yale Institute for Global Health
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology)
Associate Professor of Medicine (Pulmonary); Director, Newington VA Pulmonary Clinic, Medicine; Co-Director, Yale Center for Asthma and Airway Diseases
Professor of Neurology; Professor of Genetics, Genetics
Paul B. Beeson Professor of Medicine (Rheumatology) and Professor of Immunobiology; Paul B. Beeson Professor of Medicine; Program Director, Investigative Medicine
Eugene Higgins Professor of Immunobiology and Professor of Cell Biology
Assistant Professor of Surgery (Cardiac)
Associate Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine) and of Microbial Pathogenesis; Director, Center for Pulmonary Infection Research and Treatment (CPIRT)
Associate Professor Adjunct
Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases) and Professor of Epidemiology (Microbial Diseases) and of Microbial Pathogenesis; Affiliated Faculty, Yale Institute for Global Health; Section Chief, Infectious Diseases
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Assistant Professor of Laboratory Medicine and Immunobiology
Evans Professor of Dermatology; Director, Residency Program, Dermatology; Vice Chair, Dermatology; Co-Director, T32 Research Fellowship Program, Dermatology
- February 25, 2022
Iwasaki Is Named a Sterling Professor
- February 14, 2022
Nasal Approach to COVID Vaccination Gains Traction
- February 11, 2022Source: The Washington Post
Bob Saget died of head injury after falling, autopsy says. Here’s what to know about head trauma.
- February 09, 2022
Scientists Apply High-resolution, Single-cell Profiling to Understand Immune Response in Severe COVID-19